(S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethan-1-amine hydrochloride, 98%, 10g

Methyl 4'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1'-biphenyl]-3-carboxylate, 96%, 1g

Methyl 2-chloro-6-(hydroxymethyl)nicotinate, 95%, 1g

2-Chloro-7,8-dihydroquinazolin-5(6H)-one, 97%, 1g

3-Bromo-2-(difluoromethyl)pyridine, 95%, 1g

2-Phenylpyrimidine-4-carboxylic acid, 95.0%, 5g

2-Methoxy-N-methyaniline, 96.0%, 10g

trans-4-(Benzyloxycarbonylamino)cyclohexanecarbaldehyde, 97.0%, 500mg

1-Benzyl-3,3-difluoropiperidine-4,4-diol, 95.0%, 1g

4-Methyl-1,4-diazepan-5-one, 95.0%, 100mg

Diethylene Glycol Bis(2-chloroethyl) Ether>97.0%(GC)100g

5-Bromo-6-chloro-1H-indol-3-yl acetate, 95.0%, 250mg

Chlorure d'indium(III), min 99,9 %, pa, 50 g, emballage plastique.